Deutetrabenazine

DRUG2 trials

Sponsors

Vanderbilt University Medical Center, Teva Branded Pharmaceutical Products R&D LLC

Conditions

ChoreaHuntington DiseaseHuntington's Disease

Phase 2

Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Disease

Active, not recruitingNCT04713982

Vanderbilt University Medical CenterHuntington Disease

Start: 2021-11-19End: 2027-10-01Target: 30Updated: 2026-08-05

Phase 4

Real World Effectiveness and Safety of Deutetrabenazine in Adult Chinese Participants With Huntington's Disease (HD) Chorea in China

CompletedNCT07601516

Teva Branded Pharmaceutical Products R&D LLCChorea, Huntington's Disease

Start: 2024-02-02End: 2025-10-24Updated: 2026-08-27